证券代码：688755 证券简称：汉邦科技 公告编号：2025-019 江苏汉邦科技股份有限公司 关于变更公司经营范围暨修订 <公司章程> 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 江苏汉邦科技股份有限公司（以下简称"公司"）于 2025 年 8 月 25 日召开 第一届董事会第二十二次会议，审议通过《关于变更公司经营范围暨修订 <公司> 章程>的议案》，尚需提交公司股东会审议。具体情况如下： 一、变更经营范围的情况 根据公司业务发展需要，依照企业经营范围登记管理规范性要求，拟对公司 经营范围进行变更。具体变更情况如下: 本次变更前经营范围： 液相色谱柱、动态轴向压缩柱、静态轴向压缩柱、液相色谱仪器、超临界流 体色谱仪器、蛋白纯化色谱仪器、制备液相色谱系统设备、模拟移动床色谱系统 设备、蛋白纯化系统设备、超临界色谱系统设备、渗透汽化分离设备、溶剂回收 及纯化设备、生物大分子层析柱、生物大分子层析系统设备和超滤系统设备的研 发、制造、销售；仪器配件加工、销售；分析试剂、日用化学品、玻璃仪器、机 电设备销售及技术 ...

江苏汉邦科技股份有限公司 章 程 江苏汉邦科技股份有限公司 章程 目 录 江苏汉邦科技股份有限公司 章 程 第一章 总 则 第一条 为维护江苏汉邦科技股份有限公司（以下简称"公司"）、股东、职 工和债权人的合法权益，规范公司的组织和行为，根据《中华人民共和国公司法》 （以下简称《公司法》）、《中华人民共和国证券法》（以下简称《证券法》）、 《上市公司章程指引》、《上海证券交易所科创板股票上市规则》和其他有关规 定，制订本章程。 第二条 公司系依照《公司法》和其他有关规定成立的股份有限公司。 公司系由江苏汉邦科技股份有限公司全体股东作为发起人，并于 2022 年 2 月 25 日整体变更设立的股份有限公司，在淮安市行政审批局注册登记，取得营 业执照，统一社会信用代码为 913208917038195227。 第三条 公司经上海证券交易所审核并经中国证券监督管理委员会于 2025 年 3 月 4 日注册，首次向社会公众发行人民币普通股 2,200 万股，于 2025 年 5 月 16 日在上海证券交易所科创板上市。 第四条 公司注册名称：江苏汉邦科技股份有限公司。 英文名称：Jiangsu Hanbon Scie ...

Core Viewpoint - Jiangsu Hanbang Technology Co., Ltd. is convening its first extraordinary general meeting of shareholders in 2025 to discuss significant changes including alterations to the company's registered capital, type, business scope, and governance structure [1][5]. Group 1: Meeting Procedures - Shareholders and their proxies must register 30 minutes before the meeting and present necessary identification to attend [1][2]. - After the meeting starts, attendance registration will cease, and latecomers will not be allowed to vote [2]. - The meeting will follow a predetermined agenda for reviewing and voting on proposals [2][5]. Group 2: Proposals Overview - The primary proposal includes changes to the company's registered capital, type, and business scope, as well as the cancellation of the supervisory board and amendments to the company’s articles of association [5][10]. - The company plans to increase its registered capital from RMB 66 million to RMB 88 million following its initial public offering of 22 million shares on May 16, 2025 [7]. - The business scope will be expanded to include new areas such as mechanical equipment research and development, software development, and various manufacturing activities [7][8]. Group 3: Governance Changes - The company will abolish the supervisory board, transferring its powers to the audit committee of the board of directors [8][9]. - Amendments to the articles of association will be proposed, with the aim of enhancing corporate governance and operational efficiency [10]. - The revised articles and related documents will be disclosed on the Shanghai Stock Exchange website [9][10].

Core Points - Jiangsu Hanbon Technology Co., Ltd. has announced changes to its registered capital, company type, business scope, and governance structure, including the cancellation of the supervisory board and amendments to the Articles of Association [1][2][5] Capital and Company Type Changes - The registered capital of the company will increase from RMB 66 million to RMB 88 million following the initial public offering of 22 million shares [2][8] - The company type will change from "non-listed limited company" to "listed limited company" as it is now listed on the Sci-Tech Innovation Board [2][8] Business Scope Changes - The business scope will be updated to include the research, manufacturing, and sales of various chromatography columns and instruments, as well as special equipment and technology services [3][4][9] - The new business scope will also encompass the manufacturing and sales of mechanical equipment, biochemistry products, and software development [4][9] Governance Structure Changes - The supervisory board will be abolished, and its functions will be transferred to the audit committee of the board of directors [5][6] - The Articles of Association will be revised to reflect these changes, with specific amendments highlighted in the accompanying documents [5][6] New and Revised Governance Systems - The company will introduce and amend several governance systems to enhance operational standards and protect shareholder rights [6][7] - The revised Articles of Association and governance systems will be disclosed on the Shanghai Stock Exchange website [6][7]

Investment Rating - The investment rating for the company is "Accumulate" [6] Core Views - The company is expected to see a profit turning point due to high profitability and gradual release of profit elasticity. The gross profit margin for 2024 is projected at 70.22%, a year-on-year decrease of 7.85 percentage points, primarily due to the lower margin impact from the consolidation of Fuli Instruments. The core products, chromatography fillers and chromatography media, maintain a gross profit margin of 81.56%, with a slight year-on-year decline of 2.39 percentage points. The company’s unique ability to self-produce core raw materials, microspheres, is expected to further highlight its competitive edge, supporting a high level of gross margin for core products [2][4]. Financial Performance - In 2024, the company achieved revenue of 782 million yuan, a year-on-year increase of 33.33%. The net profit attributable to the parent company was 82.84 million yuan, up 20.82% year-on-year. In Q1 2025, the company reported revenue of 189 million yuan, a year-on-year growth of 22.39%, and a net profit of 29.22 million yuan, reflecting a 72.98% increase year-on-year [9][11]. Growth Potential - The company is positioned to benefit from accelerated domestic substitution and its own product strength and platform-driven growth. The core business of chromatography fillers and chromatography media is expected to continue its growth trend, with Q1 2025 revenue reaching approximately 111 million yuan, a year-on-year increase of about 10.62%. The strategic focus on high-quality clients is anticipated to further enhance operational quality [4][9]. Earnings Forecast and Valuation - The company’s revenue is projected to reach 966 million yuan in 2025, with a year-on-year growth of 23.44%. The net profit attributable to the parent company is expected to be 139 million yuan, reflecting a significant year-on-year increase of 68.00%. The earnings per share (EPS) for 2025 is estimated at 0.34 yuan, with a price-to-earnings (P/E) ratio of 66 times based on the closing price on May 8, 2025 [4][11].

特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 仪粉e r们，今天是高薪精品仪器职位专辑，有不少 新的雇主 哦！ 销售精英，热招职位 Ho t r e c r u itme n t p o siti o n s 上海屹尧仪器科技发展有限公司 长沙 | 销售经理 | 1 0 k - 2 0 k · 1 4薪 岗位要求： 化学/化工/食品/环保/制药等专业本科以上学历，分析化学专业优先考虑；五年以上相关销售经验，具备化学实验室工作经 验者优先。 北京普析通用仪器有限责任公司 杭州 | 销售经理 | 面议 岗位要求： 本科以上学历，分析化学或仪器专业优先；一年以上光谱类、色谱类产品销售相关工作经验优先。 上海北裕分析仪器股份有限公司 南昌 | 销售员 | 面议 岗位要求： 本科及以上学历，化学、环境、仪器仪表等相关专业优先；5年以上销售工作经验优先。 北京盈盛恒泰科技有限责任公司 上海 | 区域经理 | 8 k - 1 5 k · 1 2薪 岗位要求： 医药制药、食品、化学、生物、卫生、环境、材料、仪器仪表等相关联的专业，本科以上学历（研 ...